|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in South Korea |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Février 2007 |
Taille du document : |
18 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
1 520,00 €
|
| |
| |
OTC Pharmaceuticals in China
151 pages | Novembre 2002 |
This new report on the market for over-the-counter (OTC) pharmaceuticals in the People’s Republic of China.
The report covers the following sectors: Analgesics, Cough, cold and allergy (hay-fever) |
1 065,00 €
|
| |
| |
US First Aid 2004
16 pages | Juillet 2004 |
Snapdata's US First Aid 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US first aid market, and covers trea |
240,00 €
|
| |
| |
US Mineral Supplements 2004
12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US mineral supplement mark |
240,00 €
|
| |
| |
UK Analgesics 2004
12 pages | Juillet 2004 |
Snapdata's UK Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK analgesic market, and covers non |
240,00 €
|
| |
| |
US Family Planning 2004
12 pages | Novembre 2004 |
Snapdata's US Family Planning 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US family planning market, and |
240,00 €
|
| |
| |
Poland Contraceptives 2004
12 pages | Juillet 2004 |
Snapdata's Poland Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the Polish contraceptive market |
240,00 €
|
| |
| |
US Acne Treatments 2004
14 pages | Juillet 2004 |
Snapdata's US Acne Treatments 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US acne treatments market.
|
240,00 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
2 443,75 €
|
| |
| |
US Cough Cold & Throat Remedies 2004
16 pages | Juillet 2004 |
Snapdata's US Cough Cold & Throat Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough, cold an |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in South Korea |
|
|
Datamonitor's OTC Pharmaceuticals in South Korea industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by both value and volume
* Market shares are covered by manufacturer and/or brand
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition - The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indigestion preparations, medicated skin products, traditional medicines, vitamins and minerals and other OTC healthcare products at retail selling price (RSP) and includes any applicable taxes. The data in this industry profile is based on the most recent figures available at the time of publication and any currency conversions used in the creation of this report have been calculated using constant 2005 annual average exchange rates.
For the purposes of this report, Asia-Pacific is deemed to consist of Australia, China, India, Japan, Singapore, South Korea and Taiwan.
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Competitive Landscape 13
CHAPTER 7 Leading Companies 14
7.1 Dong Wha Pharmaceutical 14
7.2 Sanofi-Aventis Group 14
7.3 Samik Pharmaceuticals Company Limited 14
CHAPTER 8 Distribution 15
CHAPTER 9 Market Forecasts 16
9.1 Market Value Forecast 16
CHAPTER 10 Macroeconomic Indicators 17
CHAPTER 11 Further Reading 18
11.1 Sources 18
11.2 Related Datamonitor Research 18
LIST OF TABLES
Table 1: South Korea OTC Pharmaceuticals Market Value: $ billion, 2002-2006 9
Table 2: South Korea OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 10
Table 3: South Korea OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 11
Table 4: South Korea OTC Pharmaceuticals Market Share: % Share, by Value, 2004 12
Table 5: South Korea OTC Pharmaceuticals Distribution: % Share, by Value, 2004 15
Table 6: South Korea OTC Pharmaceuticals Market Value Forecast: $ billion,
2006-2011 16
Table 7: South Korea GDP (1995=100), 2002-2006 17
Table 8: South Korea Inflation, 2002-2006 17
Table 9: South Korea Exchange Rate, 2002 17
|
|
|
PPLSEN
|
|
|
|
|
